GlassScriptPhysician profile
Frank H Snipes
NPI 1245227081
$6,089.64
in general payments reported to CMS, 2019-2025
44 companies · $722 in 2025
The $722 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $296 · 2021: $1,179 · 2022: $869 · 2023: $986 · 2024: $1,374 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,067 · Entertainment: $14.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,066.83 |
| Entertainment | $14.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $830.96 | 2020-2025 | Otezla, Repatha, Krystexxa |
| Janssen Pharmaceuticals, INC | $636.52 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $522.38 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $514.94 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $504.56 | 2019-2025 | Synthroid |
| Lilly USA, LLC | $285.51 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $267.86 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $251.97 | 2019-2025 | Xifaxan |
| Idorsia Pharmaceuticals US INC | $201.56 | 2022-2023 | Quviviq |
| Boston Scientific Corporation | $193.44 | 2024 | Intracept |
| Exact Sciences Corporation | $182.47 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $133.72 | 2021-2025 | Veozah |
| Sanofi-Aventis U.S. LLC | $118.26 | 2019 | |
| Medtronic, INC. | $114.40 | 2023-2024 | Intellis Adaptivestim |
| Heartflow, INC. | $111.91 | 2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Snipes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.